154 related articles for article (PubMed ID: 9052410)
1. Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
Bhattacharya D; Redkar A; Mittra I; Sutaria U; MacRae KD
Br J Cancer; 1997; 75(4):554-8. PubMed ID: 9052410
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix.
Suzuki Y; Nakano T; Arai T; Morita S; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1229-34. PubMed ID: 10889376
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen and progesterone receptors in carcinoma of the cervix.
Harding M; McIntosh J; Paul J; Symonds RP; Reed N; Habeshaw T; Stewart M; Leake RE
Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):313-7. PubMed ID: 2278888
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.
Shen K; Yueng W; Ngan H
Chin Med J (Engl); 1994 Sep; 107(9):648-52. PubMed ID: 7805454
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma.
Vargas Roig LM; Lotfi H; Olcese JE; Lo Castro G; Ciocca DR
Anticancer Res; 1993; 13(6B):2457-63. PubMed ID: 7907850
[TBL] [Abstract][Full Text] [Related]
6. The effects of oestrogens and progesterone on oestrogen receptors in female rat liver.
Marr W; Elder MG; Lim L
Biochem J; 1980 Sep; 190(3):563-70. PubMed ID: 7470070
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma].
Shen K; Yueng W; Ngan H
Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):284-8, 317-8. PubMed ID: 7956553
[TBL] [Abstract][Full Text] [Related]
8. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid hormones and receptors in relation to S-phase fraction and ploidy level in endometrial carcinoma.
Boman K; Mäentausta O; Bäckström T; Strang P; Stendahl U
Anticancer Res; 1995; 15(3):999-1002. PubMed ID: 7645992
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene.
Valavaara R; Tuominen J; Johansson R
Cancer; 1990 Dec; 66(11):2264-9. PubMed ID: 2147123
[TBL] [Abstract][Full Text] [Related]
12. Close correlation between progesterone receptor concentration and hormonal sensitivity in DMBA-induced mammary tumours of the rat.
Mobbs BG
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):835-42. PubMed ID: 6409617
[TBL] [Abstract][Full Text] [Related]
13. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
14. Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study.
Fabian CJ; Kimler BF; McKittrick R; Park CH; Lin F; Krishnan L; Jewell WR; Osborne CK; Martino S; Hutchins LF
Cancer Res; 1994 Oct; 54(20):5357-62. PubMed ID: 7923165
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix.
Ghandour FA; Attanoos R; Nahar K; Gee JW; Bigrigg A; Ismail SM
Histopathology; 1994 Jan; 24(1):49-55. PubMed ID: 8144142
[TBL] [Abstract][Full Text] [Related]
16. Characterization of steroid hormone sensitivity in human breast cancers maintained ex vivo under organotypical culture conditions.
Darro F; Schwarz G; Pétein M; Schwarz S; Chaboteaux C; Nogaret JM; Decaestecker C; Salmon I; Kiss R
J Cancer Res Clin Oncol; 2000 May; 126(5):257-62. PubMed ID: 10815760
[TBL] [Abstract][Full Text] [Related]
17. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
Fernandez MD; Alaghband-Zadeh J; Burn JI
Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen and progesterone receptor expression influences DNA ploidy and the proliferation potential of breast cancer cells.
Andronas M; Dlay SS; Sherbet GV
Anticancer Res; 2003; 23(3C):3029-39. PubMed ID: 12926157
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
[TBL] [Abstract][Full Text] [Related]
20. The effects of sequential treatment with ethynyloestradiol and medroxyprogesterone acetate on oestrogen and progestogen receptors in breast cancer.
Ghilchik M; Shaikh NA; Beranek PA; Reed MJ; Braunsberg H
J Steroid Biochem; 1989; 34(1-6):403-5. PubMed ID: 2533948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
